| Market Capitalization (Millions $) |
5,271 |
| Shares
Outstanding (Millions) |
497 |
| Employees |
9,300 |
| Revenues (TTM) (Millions $) |
4,439 |
| Net Income (TTM) (Millions $) |
338 |
| Cash Flow (TTM) (Millions $) |
116 |
| Capital Exp. (TTM) (Millions $) |
161 |
Elanco Animal Health Inc
Elanco Animal Health Inc. is a global animal health company headquartered in Greenfield, Indiana, in the United States. The company develops, produces, and markets innovative products for animal health, including veterinary drugs, vaccines, feed additives, and other products for animal health and productivity. Elanco provides animal health products to farmers, pet owners, and veterinarians worldwide.
Elanco was founded in 1954 as a division of Eli Lilly and Company, a pharmaceutical company. In 2018, Elanco was spun off from Eli Lilly and Company to become a standalone company. Elanco has more than 6,000 employees and operates in more than 90 countries worldwide.
Elanco offers a wide range of animal health products for various species, including cattle, swine, poultry, fish, pets, and other companion animals. The company's products are built on innovative technologies that help improve animal health, welfare, and productivity.
Elanco's product portfolio includes antibiotics, parasiticides, vaccines, anticoccidials, enzymes, and other feed additives. The company has a strong presence in global markets, particularly in North America, Europe, and Asia Pacific.
In addition to its commercial products, Elanco is committed to developing sustainable solutions to address the challenges facing the animal farming industry. The company invests in research and development of new products and solutions that promote animal welfare and sustainability.
Elanco has a strong commitment to corporate social responsibility and sustainability. The company focuses on improving animal welfare, protecting the environment, and engaging in social responsibility initiatives in the communities where it operates. Elanco is a member of the United Nations Global Compact, a voluntary initiative that promotes sustainable and socially responsible business practices.
Overall, Elanco has a strong reputation in the animal health industry as a leading provider of innovative and effective animal health products. The company's commitment to sustainability and corporate social responsibility has earned it recognition as a responsible and ethical corporate citizen.
Company Address: 2500 INNOVATION WAY GREENFIELD 46140 IN
Company Phone Number: 352-6261 Stock Exchange / Ticker: NYSE ELAN
|
0.67% 
47.28 %